Bionano Genomics (BNGO) Assets (2017 - 2025)
Bionano Genomics (BNGO) has disclosed Assets for 9 consecutive years, with $73.6 million as the latest value for Q4 2025.
- Quarterly Assets fell 4.03% to $73.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $73.6 million through Dec 2025, down 4.03% year-over-year, with the annual reading at $73.6 million for FY2025, 4.03% down from the prior year.
- Assets hit $73.6 million in Q4 2025 for Bionano Genomics, down from $79.1 million in the prior quarter.
- In the past five years, Assets ranged from a high of $384.9 million in Q1 2021 to a low of $73.6 million in Q4 2025.
- Historically, Assets has averaged $224.9 million across 5 years, with a median of $242.9 million in 2023.
- Biggest five-year swings in Assets: soared 1914.77% in 2021 and later crashed 64.24% in 2024.
- Year by year, Assets stood at $377.1 million in 2021, then dropped by 18.46% to $307.5 million in 2022, then tumbled by 30.28% to $214.4 million in 2023, then plummeted by 64.24% to $76.7 million in 2024, then fell by 4.03% to $73.6 million in 2025.
- Business Quant data shows Assets for BNGO at $73.6 million in Q4 2025, $79.1 million in Q3 2025, and $76.0 million in Q2 2025.